Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers and advocates strive to offer patients a more accurate window into a drug’s impact on daily life.
All participants with detectable HIV on oral meds achieved viral suppression after switching to long-acting injectables.
TDF/FTC is effective for cisgender women who take at least four pills per week, but many struggle to reach this level of adherence.
Doxycycline after sex reduces the risk of gonorrhea, chlamydia and syphilis for gay men, and it does not appear to drive resistance.
People with HIV who recently used marijuana were twice as likely to miss taking their meds.
People with untreated depression are more likely to be nonadherent to antiretroviral treatment, but antidepressants remove the disparity.
The long-acting regimen will enable some adolescents to take their HIV treatment just six times a year.
The exhibit tells the story of her life, says Kia LaBeija, and that includes her mom, HIV, ballroom, love and a double rainbow. [SLIDESHOW]
HIV stigma and worries about disclosure were also associated with lower odds of taking treatment as prescribed.
Having trouble adhering to your medications? There are solutions to the problem.
Injections given every month or every other month were preferred over daily pills.
Middle-aged Black adults living with HIV reported substantial economic impact of COVID-19 and high medical mistrust.
Kenya has been using similar technology for three years. DC’s efforts are among the first in the United States.
A new study indicates that the level of adherence required for viral suppression may be lower than previously understood.
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.